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ABSTRACT 35 
The role of polymicrobial biofilm infections in medicine is becoming more 36 
apparent. Increasing numbers of microbiome studies and deep sequencing 37 
has enabled us to develop a greater understanding of how positive and 38 
negative microbial interactions influence disease outcomes. An environment 39 
where this is particularly pertinent is within the oral cavity, a rich and diverse 40 
ecosystem inhabited by both bacteria and yeasts, which collectively occupy 41 
and coexist within various niches as biofilm communities. Studies within this 42 
environment have however tended to be subject to extensive independent 43 
investigation, in the context of either polymicrobial bacterial communities or 44 
yeast biofilms, but rarely both together. It is clear however that they are not 45 
mutually exclusive. Therefore, this review aims to explore the influence of 46 
candidal populations on the composition of these complex aggregates and 47 
biofilm communities, to investigate their mechanistic interactions to understand 48 
how these impact clinical outcomes, and determine whether we can translate 49 
how this knowledge can be used to improve patient management.  50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
 3 
Introduction 69 
Candida biofilms, in particular C. albicans, are an important healthcare issue 70 
due to ineffective clinical management strategies. Over the past 20 years we 71 
have learned a great deal about their clinical importance, including the 72 
mechanisms used by members of the genus to form biofilms and resist the 73 
challenge of host and antimicrobial molecules (Nett, 2014, Ramage et al., 74 
2014). However, as our levels of knowledge have increased, in part through 75 
the development of more sophisticated technologies, there has been a 76 
growing awareness that Candida rarely exist within a mono-species 77 
environment, and that heterogeneous biofilm populations consisting of 78 
aggregates of other fungi and bacteria (Gram-positive and Gram-negative) are 79 
in fact a highly prevalent and clinically important entity (Figure 1).  80 
 81 
One location within the body where Candida species are readily isolated is 82 
within the oral cavity. Traditionally oral microbiologists have invested 83 
significant time and effort unravelling the importance of specific bacterial-84 
bacterial interactions, while investigations of polymicrobial interactions have 85 
not received the same level of attention. This has led to a disparity of 86 
fundamental knowledge on the significance of candidal-bacterial interactions 87 
within the oral environment. The clinical implications of these polymicrobial 88 
biofilm interactions, primarily relates to recalcitrance to antimicrobial treatment 89 
strategies. Moreover, there is growing evidence from the literature that 90 
polymicrobial interactions may synergise the pathogenic potential of one or 91 
other microorganism (Stacy et al., 2014). This only serves to highlight the 92 
importance of a dual approach to microbial analysis, where mycological and 93 
bacteriological analysis can have an equal contribution through 94 
interdisciplinary collaboration (Holmes et al., 1995). This review aims to 95 
critically evaluate the available evidence as a means of appraising the clinical 96 
importance of Candida biofilms in polymicrobial environments, using key oral 97 
diseases and groups of microorganisms to illustrate these points. 98 
 99 
Polymicrobial candidal interactions in the oral cavity 100 
Oral candidosis is one of the most well-defined fungal biofilm infections of both 101 
soft and hard tissue and is characterised by complex biofilms which interact 102 
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with bacteria and the host (Dongari-Bagtzoglou et al., 2009, Rautemaa & 103 
Ramage, 2011). The oral cavity provides a key portal of entry within the 104 
human host, and is home to a rich and diverse microbial flora. Despite being 105 
bathed in saliva, an important innate defence mechanisms containing 106 
numerous antimicrobial molecules, the oral cavity is a favourable habitat for 107 
both prokaryotes and eukaryotes. Within this, it is suggested that up to 108 108 
microbes per millilitre of saliva are present (Guo & Shi, 2013). The oral cavity, 109 
therefore, acts as an important incubator for a complex ‘microbial soup’, in 110 
which yeasts such as Candida interact with one-another and with a plethora of 111 
cultivatable and non-cultivatable bacterial species, primarily within biofilm 112 
communities. Advances in genome sequencing are only now beginning to 113 
shed light on the importance of Candida within these complex communities 114 
(Nobbs & Jenkinson, 2015). Microbiome analysis of the saliva from elderly 115 
Dutch patients showed that an increased candidal load was associated with a 116 
dysbiotic bacterial flora that favoured the co-existence with oral streptococci to 117 
the exclusion of pathogenic anaerobic species (Kraneveld et al., 2012). 118 
Candida species have been isolated from a range of oral environments 119 
involving both soft and hard tissue of biological and non-biological origin, 120 
illustrating the adaptability of candidal yeasts (Figure 2). The sites from which 121 
C. albicans has been isolated include periodontal pockets, root canals, 122 
orthodontic appliances, enamel, dentures and mucosal surfaces (Ramage et 123 
al., 2004, de Carvalho et al., 2006, Arslan et al., 2008, Dongari-Bagtzoglou et 124 
al., 2009, Sardi et al., 2010, Freitas et al., 2014). In order for candidal biofilms 125 
to flourish in these environments, moisture, nutrients, hyphal growth and the 126 
presence of commensal bacteria are all required which influence C. albicans 127 
architecture and virulence (Bertolini et al., 2015). 128 
 129 
Caries 130 
Dental caries is one of the most common diseases worldwide, impacting 2.43 131 
billion (36% of the global population) (Vos et al., 2012). Largely influenced by 132 
diet caries has a multifactorial aetiology involving behavioural, environmental 133 
and immunological factors. Microbial dental plaque biofilms adherent to tooth 134 
surfaces, play a key role in the development of dental caries, through 135 
carbohydrate metabolism (predominantly sucrose) leading to production of 136 
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large quantities of lactic acid, and ultimately the dissolution of tooth surfaces. 137 
Typically, caries has been associated primarily with Streptococcus mutans and 138 
Lactobacillus species (Loesche, 1986, Badet & Thebaud, 2008), although 139 
more recently, oral microbiome studies have highlighted the polymicrobial 140 
aetiology of carious lesions (Belda-Ferre et al., 2012, Simon-Soro et al., 2014). 141 
Historically, candidal yeasts have been isolated in patients with caries (Krasse, 142 
1954, Koo & Bowen, 2014), though the evidence for their direct role has yet 143 
been shown directly. There is now growing evidence that C. albicans actively 144 
participates in cariogenic biofilms, through synergistic interaction with S. 145 
mutans (Metwalli et al., 2013, Koo & Bowen, 2014). Evidence of enhanced 146 
exopolymeric matrix production, facilitated by the increased surface area 147 
associated with hyphal networks, supports mixed biofilm growth of dense 148 
communities cemented to tooth enamel. Based on this and other studies, the 149 
interaction between candidal yeasts and streptococci is an important area 150 
requiring further extensive investigation. 151 
 152 
Periodontal disease 153 
Periodontal disease (PD) is a complex disease orchestrated by host-pathogen 154 
interactions. It affects almost 50% of the US population under 30 years old, 155 
and by the time they reach 65 years of age approximately 70% are affected 156 
(Eke et al., 2012). In its mild and reversible form (gingivitis) the gingival tissues 157 
are characterised by swelling, an inflamed gum line and bleeding, whereas in 158 
its severe and irreversible form (periodontitis) there is destruction of the 159 
supporting periodontal ligaments and progressive bone resorption. While 160 
dysregulated inflammatory responses are pivotal with respect to periodontitis, 161 
the initial catalytic stimuli common to both forms of the disease comes from 162 
complex microbial biofilms. These initially establish themselves above the gum 163 
line (supra-gingival plaque), alter the microenvironment and drive a lower 164 
redox and pH, thus enabling capnophiles and anaerobes to colonise and 165 
produce sub-gingival plaque biofilms. The microbiology of supra- and sub-166 
gingival plaque is extremely well characterised, with the influence of defined 167 
groupings of commensal and pathogenic species accurately mapped to clinical 168 
outcomes (Ximenez-Fyvie et al., 2000, Shi et al., 2015). With this historical 169 
focus on defined bacterial groupings defined by Socransky’s traffic light 170 
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analogy (Socransky et al., 1998), there has been minimal interest with respect 171 
to the influence of candidal species (Holmstrup, 1999). This is surprising given 172 
that Candida species have also been isolated from subgingival mixed biofilm 173 
consortia in patients with severe chronic periodontitis, where quantitatively 174 
high levels of C. albicans were shown to correlate with moderate and severe 175 
chronic periodontitis (Canabarro et al., 2012). There is, however, a lack of 176 
direct evidence for causality, although in diabetes patients the relationship 177 
between subgingival candidal colonisation and periodontitis is more apparent 178 
(Sardi et al., 2012, Hammad et al., 2013). This relationship maybe a 179 
consequence of metabolic requirements, with elevated blood sugar levels 180 
supporting the growth of Candida species. Further evidence for Candida’s 181 
involvement follows the use of oral contraceptives (OC), by which several 182 
studies have found an increased prevalence of Candida spp. carriage, as well 183 
as higher incidences of oral and vaginal candidiasis amongst OC users 184 
(Spinillo et al., 1995, Kazi et al., 2012, Zakout et al., 2012). Furthermore, the 185 
prevalence of severe periodontitis is higher amongst OC users, suggesting 186 
that the hormones lead to the development of a dysbiotic biofilm, enabling 187 
Candida yeast to colonise (Brusca et al., 2010). Irrespective of why Candida 188 
spp. are present in this environment, we do know that the subgingival 189 
environment represents a highly diverse microbial ecosystem comprised of a 190 
variety of commensals and pathogens, ranging from benign streptococcal 191 
species to virulent Porphyromonas gingivalis (Socransky & Haffajee, 2005, 192 
Haffajee & Socransky, 2006). Here, competition for nutrients, gases and 193 
space, dictate biofilm structure, and it is likely that the larger Candida cells play 194 
a significant physical and chemical role. 195 
 196 
Endodontic infection 197 
Endodontitis can result from direct tooth trauma, carious lesions on the 198 
enamel surface, or from periodontal infection progressing to the root apex. It 199 
is characterised by an infection of the pulp within the dental root canal system 200 
and is the major aetiologic agent of apical periodontitis. The American 201 
Association of Endodontists estimate that over 15 million root canal 202 
treatments are performed annually in the US, and these are primarily of an 203 
infectious origin. Endodontic infections are typically of biofilm aetiology and 204 
 7 
are associated with key oral bacterial pathogens from up to 100 different 205 
bacterial genera (Siqueira & Rocas, 2009), by and large from 4 key phyla 206 
(Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria), although 207 
Enterococcus faecalis is considered the primary aetiological agent. 208 
Nonetheless, due consideration should be made to the method employed 209 
(culture versus non-culture) when assembling the snapshot of the dominant 210 
microbiota, as this heavily biases our perception of which species are 211 
important. In fact, this is a pertinent point to all oral diseases. Endodontic 212 
biofilms tend to reflect their origin, i.e. those from cariogenic lesion on occlusal 213 
surfaces may be more similar to supra-gingival plaque whereas those in 214 
periapical infection may reflect a predominantly anaerobic environment. There 215 
is increasing evidence for the involvement of Candida species in endodontic 216 
infections (Siqueira & Sen, 2004). Its’ role as a dentophilic pathogen are 217 
highlighted through in vitro studies of dentine, where penetration of dentine 218 
tubules with C. albicans was demonstrated (Sen et al., 1997). Subsequent 219 
studies have confirmed the presence of C. albicans from clinical root canal 220 
specimens (Baumgartner et al., 2000), with subsequent studies showing an 221 
association between C. albicans and E. faecalis  (Peciuliene et al., 2001). In 222 
spite of this evidence of polymicrobiality there are no studies describing the 223 
candidal-bacterial interactions in the root canal environment.  224 
 225 
Denture stomatitis 226 
Edentulousness is an irreversible clinical condition that can be described as 227 
an ultimate marker of oral disease burden and is often associated with 228 
socioeconomic factors (Jeganathan & Lin, 1992, Cunha-Cruz et al., 2007). 229 
Denture stomatitis (DS) refers to inflammation of the oral mucosa and 230 
pathological changes associated with denture surfaces adjacent to tissue 231 
(Jeganathan & Lin, 1992). Approximately two thirds of individuals who wear 232 
removable complete dentures suffer from DS, though most individuals are 233 
asymptomatic (Gendreau & Loewy, 2011). With 15 million dentures wearers in 234 
the UK this is not an inconsequential disease (Coulthwaite & Verran, 2007). 235 
Many factors influence its onset and severity, including salivary flow and 236 
denture cleanliness amongst others (Oksala, 1990, Soysa et al., 2004, Soysa 237 
& Ellepola, 2005, Soysa et al., 2006), although microbial factors remain one of 238 
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the most important. Dentures support the growth of microbial biofilms (denture 239 
plaque) within tiny cracks and fissures. These polymicrobial biofilm 240 
communities dominate the denture surface, with up to 1011 microbes per 241 
milligram of denture plaque (Nikawa et al., 1998), which take advantage of the 242 
varied topography associated with denture acrylics and resins (Ramage et al., 243 
2004). Some of the bacterial species isolated include periodontal pathogens 244 
such as Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans 245 
and Porphyromonas gingivalis (Sachdeo et al., 2008, Yasui et al., 2012), 246 
although caries-associated species such as Streptococcus and Lactobacillus 247 
species predominate (Teles et al., 2012), possibly through their ability to 248 
coaggregate with C. albicans hyphae (Bilhan et al., 2009, Ribeiro et al., 2012). 249 
Here they form biofilms analogous to that of the enamel surface through 250 
pioneer species, followed by coaggregation and maturation of complex 251 
polymicrobial biofilms (Figure 4).  252 
 253 
Unlike the oral diseases described above, DS is generally considered to be of 254 
yeast aetiology, with the literature disproportionately focussed on Candida 255 
spp. (Coleman et al., 1997, Bagg et al., 2003, Redding et al., 2004, Li et al., 256 
2007). C. albicans is the most frequently isolated yeast from the denture, but 257 
C. glabrata, C. dubliniensis, C. tropicalis, C. krusei and a range of other 258 
Candida species have been frequently isolated (Coco et al., 2008, Williams et 259 
al., 2011). C. albicans accounts for the majority of the inflammatory pathology 260 
observed clinically (Salerno et al., 2011). It exists as a commensal in the oral 261 
cavity of 25-50% of the healthy population, and can become pathogenic under 262 
optimal conditions, such as when the immune response is compromised 263 
(Dagistan et al., 2009). This is not surprising given its dimorphic capabilities, 264 
i.e. the ability to form hyphae and yeast interchangeably, a requisite of biofilm 265 
formation (Ramage et al., 2002). The hyphal form has been more commonly 266 
isolated in DS sufferers and is assumed to be the more invasive form of the 267 
organism, with an enhanced ability to adhere to and colonise the prosthesis 268 
surface (Gendreau & Loewy, 2011, Verran et al., 2014). Collectively, these 269 
polymicrobial biofilms actively release proteolytic and lipolytic enzymes that 270 
induce inflammation of the palatal surface (Marcos-Arias et al., 2011, Ramage 271 
et al., 2012), ultimately leading to DS. The scanning electron micrograph 272 
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(SEM) in Figure 3 illustrates C. albicans interacting with bacteria on the 273 
surface of denture acrylic, with the associated confocal micrograph, showing 274 
bacteria coaggregating with C. albicans hyphae. 275 
 276 
Angular cheilitis 277 
Angular cheilitis is an inflammation of one, or more commonly both, corners of 278 
the mouth. It is a disease of multifactorial aetiology that includes anatomical 279 
issues, dry mouth, immunosuppression, and the wearing of poor fitting 280 
dentures, amongst many others. Although not particularly common per se, this 281 
disease is of interest as it is often associated with the co-isolation of Candida 282 
species with Staphylococcus aureus, microorganisms not unaccustomed to 283 
one another within the human host (Tawara et al., 1996, Adam et al., 2002, 284 
Baena-Monroy et al., 2005). Both species are leading pathogens in blood 285 
borne and systemic infections, a major cause of morbidity and mortality in 286 
hospitalized patients. These species are of significant interest because of the 287 
escalating development of antimicrobial resistance and their increasing 288 
involvement in chronic and systemic polymicrobial biofilm infections (Perlroth 289 
et al., 2007), and have been shown to co-aggregate together and exist within a 290 
dynamic and interactive state (Peters et al., 2012, Peters et al., 2012) (Shirtliff 291 
et al., 2009). The relationship between these two has been described as 292 
mutualistic, synergistic and antagonistic, yet most of the evidence indicates 293 
synergy, as the majority of their interactions are associated with enhanced 294 
pathogenicity and disease severity (Peters & Noverr, 2013, Schlecht et al., 295 
2015).  296 
 297 
Oropharyngeal and respiratory infection 298 
As described, Candida is one of the main colonisers of the oral cavity and 299 
plays an important role in many oral diseases. However, there is thought to be 300 
a potential link between oral and pulmonary colonisation of Candida, which 301 
could contribute towards respiratory infection. Studies have identified 302 
respiratory pathogens colonising the oral cavity, as well as oral pathogens 303 
colonising the lungs (El-Solh, 2011, Bansal et al., 2013, Vadiraj et al., 2013, 304 
Przybylowska et al., 2015). Amongst these, Candida has been found to be one 305 
of the most predominant pathogens in the lungs, particularly in those suffering 306 
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from lung cancer and chronic pulmonary disease (Biswas et al., 2010, 307 
Laroumagne et al., 2011, Laroumagne et al., 2013). Aspiration of oral material 308 
into the lungs is thought to be the primary entry route of oral pathogens. 309 
Therefore, given that the oral carriage rate of Candida is approximately 50% 310 
(Darwazeh et al., 2010), and that roughly 45% of healthy individuals aspirate 311 
oropharyngeal contents into their lungs whilst sleeping, this puts a high 312 
number at risk of pulmonary colonisation by Candida (Gleeson et al., 1997). 313 
Yet, despite the potential to cause infection, Candida colonisation of the lungs 314 
is not necessarily detrimental, particularly when P. aeruginosa is also isolated 315 
(Ader et al., 2011). P. aeruginosa is frequently related with ventilator 316 
associated pneumonia and cystic fibrosis, with C. albicans often co-isolated. 317 
Many studies have investigated their interactions, yet have produced 318 
conflicting results with some identifying a synergistic relationship (Roux et al., 319 
2009); however the vast majority provide stronger evidence for an antagonistic 320 
relationship (Morales et al., 2010, Bandara et al., 2013). P. aeruginosa gains 321 
the upper hand the majority of the time by preventing biofilm formation via 322 
killing of C. albicans hyphal filaments (Hogan & Kolter, 2002, Hogan et al., 323 
2004). Nonetheless, recently it has been shown in a murine model that lung 324 
injury caused by P. aeruginosa infection is alleviated if preceded by a short 325 
term C. albicans colonisation (Ader et al., 2011). This was due to C. albicans 326 
activation of innate lymphoid cells, which produced IL-22, providing protection 327 
against P. aeruginosa induced injury (Mear et al., 2014).  328 
 329 
Candida polymicrobial biofilm formation is the predominant problem 330 
associated with voice box prosthesis (VP) (Talpaert et al., 2015). Silicone is 331 
the most commonly used material used for VP, however, silicone is a 332 
favourable material for microbial attachment and can very quickly become 333 
colonised (Busscher et al., 1997). Biofilm formation can lead to valve 334 
malfunctioning, causing seepage of oesophageal contents into the trachea, 335 
which could potentially cause aspiration pneumonia (van Weissenbruch et al., 336 
1997a, van Weissenbruch et al., 1997b). C. albicans is the most common 337 
yeast associated with VP colonisation, though C. glabrata and C. tropicalis are 338 
also frequently isolated (Bauters et al., 2002). Streptococcus spp and 339 
Lactobacillus spp are the predominant bacterial species isolated (Neu et al., 340 
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1994), however the majority of mature biofilms had Candida and lactobacilli as 341 
their primary components (Buijssen et al., 2007). The success of polymicrobial 342 
biofilms forming on VP is likely due to the location, which is difficult for host 343 
immune defences to access. For the most part, it is very unusual to find a 344 
biofilm from a VP that is not comprised of both fungal and bacterial 345 
components. Before Candida can colonise the VP, there is strong evidence 346 
that bacteria must be adhered first, thus such fungal-bacteria interactions are 347 
critical for biofilm formation (Millsap et al., 2001). The more intricate details 348 
involved in these interactions requires further investigation, however what is 349 
clear is that disease resulting from microbial colonisation of a VP is very much 350 
polymicrobial in nature. 351 
 352 
Mechanisms of polymicrobial biofilm interaction 353 
Staphylococcal interactions 354 
The interaction between C. albicans and S. aureus has been associated with 355 
enhanced pathogenic behaviour, disease severity and morbidity (Nair et al., 356 
2014). They form mixed polymicrobial biofilms in which S. aureus cells are 357 
found attached to C. albicans hyphal filaments (Peters et al., 2010, Yi Jey Lin, 358 
2013) (Figure 5). Their co-localisation within biofilms is still unclear, as some 359 
describe them interspersed throughout the biofilm three-dimensional structure 360 
(Peters et al., 2010), whereas others describe them as only found attached 361 
within the upper layers of the biofilm (Harriott & Noverr, 2009). This disparity 362 
could be explained by different experimental conditions (e.g. growth medium). 363 
The initial colonising species plays a key role in dictating their interaction, as it 364 
has been shown that C. albicans biofilm formation was delayed when S. 365 
aureus colonised first, yet when added simultaneously biofilms formed rapidly 366 
(Yi Jey Lin, 2013). The reason for this inhibition is unknown; perhaps S. 367 
aureus secretes an inhibitory molecule preventing Candida adhesion. 368 
 369 
Studies in S. epidermidis have shown that extracellular DNA (eDNA) release 370 
through autolysis is an important entity in supporting mixed biofilm growth 371 
(Pammi et al., 2013), and is a featurenalso critical for C. albicans biofilm 372 
extracellular matrix (ECM) integrity (Rajendran et al., 2014, Sapaar et al., 373 
2014). Therefore, it is not surprising that eDNA and the ECM from both C. 374 
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albicans and S. aureus biofilms are both involved in affecting the action of 375 
antibacterial agents. In fact, it has been shown that S. aureus is protected 376 
against vancomycin treatment using concentrations as high as 1600mg/mL 377 
within the mixed biofilm environment, through C. albicans ECM preventing 378 
diffusion and access to S. aureus (Harriott & Noverr, 2009). There are, 379 
however, other adaptive resistance mechanisms that play a role in this 380 
resistance phenotype (Harriott & Noverr, 2010). 381 
 382 
It has also been shown that S. aureus preferentially adhere to hyphal 383 
filaments by relying on the adhesion to the C. albicans agglutanin-like 384 
sequence 3 protein (Als3p) (Peters et al., 2010, Peters et al., 2012), though it 385 
is likely that other proteins are involved. S. epidermidis have also been shown 386 
to preferentially adhere to hyphae, with forces between single bacterial and 387 
fungal germ tubes showing large adhesion forces (~5 nN) (Beaussart et al., 388 
2013).  Studies have shown that S. aureus binding to C. albicans hyphae was 389 
significantly stronger than all other bacteria tested, including P. aeruginosa 390 
(Peters et al., 2010). Interestingly, it was reported that none of the members 391 
of the ALS family of adhesins, (ALS1-7 and ALS9), including ALS3, are 392 
involved in interspecies adhesion (Harriott & Noverr, 2010).  Thus further 393 
insight is required before we can fully understand the mechanisms 394 
responsible for adherence, yet it is likely that this is a complex process in 395 
which a multitude of proteins are involved. Nevertheless, it is thought that 396 
adhesion to hyphae may assist S. aureus in penetrating into the host 397 
(Schlecht et al., 2015), a manner analogous to injection from a needle-stick 398 
injury. This has been demonstrated in mice studies, in which mixed infections 399 
with C. albicans als3∆ strains together with S. aureus were unable to invade 400 
the tongue, whereas the wild type infections demonstrated co-infection 401 
(Peters et al., 2012). The ramifications of this enhanced invasive capacity 402 
have been shown historically to impact mortality, where synergism between 403 
the co-infected species administered intraperitoneally in a mouse model, lead 404 
to 100% mortality, whereas mono-species infections caused no mortality 405 
whatsoever (Carlson, 1983).  Whether or not the relationship between the two 406 
organisms is physical or chemical remains to be determined, although there is 407 
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evidence that growth related synergy is an important factor in their co-408 
habitation of micro-niches (Carlson & Johnson, 1985). Indeed, the physical 409 
relationship between the organisms is important, but not fundamental. Recent 410 
studies indicated that morphogenesis, i.e. the presence of hyphae, is not 411 
critical for their pathogenic potential, as demonstrated in some intricate 412 
murine studies using C. albicans genetically locked into the yeast state (Nash 413 
et al., 2014).  This suggests that physical cellular interactions are not solely 414 
responsible.   415 
 416 
Metabolic signalling between C. albicans and S. aureus may play an 417 
important role in orchestrating this relationship. Chemically mediated 418 
signalling in the form of quorum sensing (QS), could potentiate both positive 419 
and negative interactions between these two microorganisms, which may 420 
inadvertently impact clinical outcomes. C. albicans secretion of farnesol, a QS 421 
molecule, decreases S. aureus biofilm formation, as well as increasing its 422 
susceptibility to antibiotics (Akiyama et al., 2002, Jabra-Rizk et al., 2006, 423 
Unnanuntana et al., 2009). Moreover, it was shown to competitively inhibit S. 424 
aureus lipase activity (Kuroda et al., 2007). However, Lin et al (2013) found 425 
that S. aureus conditioned media had a striking impact on C. albicans biofilm 426 
growth rate, indicating that S. aureus secretes a reciprocal quorum sensing 427 
molecule that stimulates C. albicans growth (Lin et al., 2013). Nonetheless, 428 
whether C. albicans secretes sufficient farnesol in vivo to have an effect on S. 429 
aureus, remains unknown. Yet despite these conflicting results, the majority of 430 
studies support the idea of a synergistic relationship between the two.  431 
 432 
Indeed, affinity panning of a S. aureus phage display library against C. 433 
albicans biofilms demonstrated that S. aureus released extracellular 434 
fibrinogen binding protein (Efb) during the interaction. This was shown to coat 435 
C. albicans yeast cells and reduce phagocytosis by granulocytes (Fehrmann 436 
et al., 2013).  In order to gain a better understanding of the molecular 437 
interaction between C. albicans and S. aureus, Peters and colleagues (2010) 438 
undertook a proteomics approach to identify proteins up-regulated during their 439 
interaction (Peters et al., 2010). The majority of the 27 proteins that were up-440 
regulated were involved in processes, including, stress and growth responses, 441 
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and metabolism. S. aureus up-regulated stress-related genes in response to 442 
both yeast and hyphae, yet, interestingly most of these genes were up-443 
regulated in response to yeast rather than hyphal biofilms. As for C. albicans, 444 
yeast cells increased a number of stress related proteins such as Tsa1p and 445 
aconitate hydratase, yet C. albicans in hyphal formation showed minimal 446 
changes in gene expression in response to S. aureus. These results suggest 447 
that both organisms induce a stress response on their initial encounter with 448 
one another, particularly whilst Candida exists in yeast form. However as they 449 
mature and develop into a hyphal biofilm, they may down regulate these 450 
genes as a survival strategy, facilitating survival within the host.  451 
 452 
Clearly, these two pathogens have the ability to influence one another’s 453 
behaviour, so care must be taken in their clinical management. Broad-454 
spectrum antimicrobial activity is crucial, accounting for both prokaryote and 455 
eukaryote. The use of ethanol has been shown to be effective at preventing 456 
both mono-and poly-microbial biofilms (Peters et al., 2013). However, the 457 
successful use of miconazole in angular cheilitis is interesting given no 458 
precise mechanism of action for this azole to S. aureus (Sud & Feingold, 459 
1982). It could therefore be hypothesised that given the polymicrobiality of the 460 
disease miconazole acts by exhibiting C. albicans activity, thereby 461 
destabilising S. aureus colonisation, which is physically supported by the 462 
hyphal biofilm meshwork. What is clear though is that these organisms are no 463 
strangers to one another.  464 
 465 
Streptococcal interactions 466 
Streptococci are amongst the primary colonisers of the oral cavity and 467 
compromise a large proportion of the overall flora (Syed & Loesche, 1978, 468 
Moore et al., 1982). Oral streptococcal species are often termed as the mitis 469 
group streptococci (MGS), which include S. mitis, S. oralis, S. gordonii, S. 470 
sanguinis and S. parasanguinis species (Kawamura et al., 1995). MGS 471 
streptococci are traditionally known to be early colonisers of dental surfaces, 472 
comprising approximately 60-80% of the flora (Diaz et al., 2012), although use 473 
of high throughput gene sequencing technology has revealed them to also be 474 
predominant colonisers of oral mucosal surfaces (Diaz et al., 2012).  475 
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 476 
The relationship between Candida and streptococci is generally considered to 477 
be synergistic, with advanced microscopy showing streptococcal interactions 478 
with the hyphal filaments of Candida (Dutton et al., 2014).  Streptococci 479 
provide Candida with nutrients from the salivary pellicle, such as lactate and 480 
glucose, which Candida utilise as a source of carbon(Holmes et al., 2006). 481 
Furthermore, streptococci are aciduric and thus create an acid environment 482 
through the fermentation of carbohydrates (Takahashi & Nyvad, 2011). At low 483 
pH Candida grows in its yeast form. However, when co-colonised with 484 
streptococci, Candida can grow and survive at a lower pH (<4.5), and the 485 
H2O2 produced by streptococci can induce hyphal growth by inducing 486 
oxidative stress (Jenkinson et al., 1990, Nasution et al., 2008). This 487 
interaction is bidirectional, as C. albicans can promote the survival of 488 
streptococci by lowering oxygen tension levels to that more acceptable for 489 
streptococcal growth, as well as providing nutrients to stimulate bacterial 490 
growth (Douglas, 2002). This synergistic relationship can prove disparaging 491 
for the host. Studies have shown that streptococci augment the persistence of 492 
Candida spp. Xu and colleagues (2014) demonstrated that co-infection with 493 
C. albicans and S. oralis resulted in a more pathogenic inflammatory 494 
response compared with infection with either microorganism alone, as 495 
demonstrated through an exaggerated up-regulation of TLR2 dependant 496 
inflammatory genes (Dutton et al., 2014, Xu et al., 2014).   497 
 498 
Adherence to mucosal surfaces occurs through binding interactions with 499 
components of the salivary pellicle, however, there is a limited number of 500 
niches for C. albicans to inhabit. Thus, C. albicans has to compete with other 501 
microbes (Kolenbrander et al., 2002). To overcome this problem C. albicans 502 
has evolved a mechanism allowing it to bind directly to MGS species, including 503 
S. oralis, S. mitis and S. gordonii (Jenkinson et al., 1990). This interaction is 504 
mutually beneficial as C. albicans can support the outgrowth of streptococci by 505 
enabling them to form more robust oral biofilms (Xu et al., 2014). Adherence 506 
between these two species occurs via interactions of the C. albicans hyphal 507 
cell wall protein Als3, and the streptococcal cell surface adhesins SspA and 508 
SspB (Holmes et al., 1996), proteins that belong to the antigen I/II polypeptide 509 
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family (Bamford et al., 2009). Als3p is one of eight Als protein family members 510 
expressed in C. albicans (Als1p-7p, Als9p). Direct binding of SspB and Als3 is 511 
required for bacterial-fungal attachment. Interaction between these molecules 512 
is associated with the N-terminal domain of Als3 (Bamford et al., 2015), as 513 
deletions at the N-terminus abrogated binding to S. gordonii. Hoyer and 514 
colleagues (2014) have demonstrated that this interaction may be more 515 
complex than originally thought by showing that the peptide-binding domain 516 
(PBD) of C. albicans is essential for C. albicans-S. gordonii adherence. The 517 
PBD functions by binding to the free C-terminus, however, in S. gordonii the 518 
SspB C-terminus is covalently linked to peptidoglycan, and is thus unavailable 519 
to bind. Further investigation is required before we can fully understand the 520 
mechanism behind this interaction, though recent studies suggest that the 521 
early stage of cell wall O-mannosylation may be important in the development 522 
of these polymicrobial communities (Dutton et al., 2014).  523 
 524 
 525 
An important component of a biofilm is the extracellular matrix (ECM), which 526 
confers protection to antimicrobials (Xu et al., 2014). The ECM of 527 
streptococcal biofilms is composed of α-glucans (Gregoire et al., 2011), 528 
whereas Candida biofilm ECM is primarily composed of β-glucans (Al-Fattani 529 
& Douglas, 2006, Taff et al., 2012). S. mutans utilises its ECM components to 530 
enhance adhesion to fungal cells by depositing α-glucans on the surface of 531 
hyphae (Gregoire et al., 2011). Moreover, interaction between S. mutans and 532 
C. albicans is promoted by glucosyltransferase-derived ECM and expression 533 
of the S. mutans virulence gene gtfB (Falsetta et al., 2014). It was also shown 534 
in this study that Candida-derived β1,3-glucans contribute to ECM matrix 535 
structure, whilst fungal β-glucan and mannan provide sites for GtfB binding 536 
and activity. Furthermore, β-glucans are found on the surface of hyphae as 537 
well as in the matrix (Dongari-Bagtzoglou et al., 2009), thus suggesting that 538 
streptococci utilise these proteins to adhere to candidal hyphae. Collectively, 539 
this suggests the biofilm ECM contributes to this mutualistic behavior, 540 
favouring their co-existence in the oral environment to the detriment of the host. 541 
 542 
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As with Candida – S. aureus interactions, quorum sensing (QS), is an 543 
important factor in the relationship between Candida and streptococci. 544 
Farnesol, a tetraprenoid alcohol and a key intermediate in the sterol 545 
biosynthetic pathway in eukaryotic cells, represents the primary QS molecule 546 
associated with C. albicans, its main role being repression of hyphal growth 547 
and biofilm formation (Ramage et al., 2002). However, one study has 548 
suggested that S. gordonii is able to suppress farnesol induced inhibition of 549 
biofilm formation, via autoinducer 2 (AI-2), as luxS mutants were less effective 550 
at permitting hyphal formation, however the mode of action has yet to be 551 
elucidated (Bamford et al., 2009). Farnesol has also been shown to inhibit S. 552 
mutans biofilm accumulation and polysaccharide production (Koo et al., 553 
2003). Based on this and further work, it has been suggested that it may be 554 
used to control its competitiveness in mixed species biofilms and could be 555 
used as a means of a chemotherapeutic strategy (Jeon et al., 2011). AI-2 is 556 
the primary QS molecule secreted by bacteria that allows inter-species 557 
communication (Vendeville et al., 2005). The luxS gene is associated with AI-558 
2 production and luxS streptococcal mutants can form monospecies biofilms. 559 
However, when co-colonised with C. albicans, biofilm formation becomes 560 
abrogated, suggesting this molecule is involved in cellular communication 561 
(McNab et al., 2003, Bamford et al., 2009). Another important signalling 562 
mechanism in streptococci, including S. gordonii, is through the comCDE 563 
operon, which encodes a sensor-regulator system (ComDE) activated by the 564 
comC gene product competence stimulating peptide (CSP). S. gordonii-C. 565 
albicans biofilms formed with ΔcomCDE or ΔcomC mutants showed 566 
increased biomass compared to wild-type biofilms. Interestingly, more eDNA 567 
was observed in the mixed ΔcomCDE mutant biofilms. Although purified CSP 568 
did not affect C. albicans hyphal formation. Contrary to earlier findings (Jarosz 569 
et al., 2009), it did inhibit monospecies biofilm formation, suggesting that the S. 570 
gordonii comCDE QS-system modulates the production of eDNA (Jack et al., 571 
2015), and important component of candidal ECM (Rajendran et al., 2014).  572 
 573 
Candidal interactions 574 
Hyphae provide C. albicans with an advantage over many of its competitors in 575 
terms of size and surface area, enabling them to take advantage of more sites 576 
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for adhesion and occupation of a variety of niches. This is why it is a more 577 
successful pathogen than other members of the genus. Nonetheless, there is 578 
hypothesis that Candida spp., in particular C. glabrata benefit from C. 579 
albicans. There have been suggestions that DS pathology may be promoted 580 
by the synergistic interaction between these species within denture biofilms. 581 
Coco and colleagues (2008) first reported that C. glabrata and C. albicans 582 
were often co-isolated from patients, particularly those with severe 583 
inflammation. The authors hypothesised that pathogenic synergy existed 584 
between the two Candida species. C. glabrata, devoid of hyphae, forms 585 
relatively structurally poor and unstable biofilms, yet is associated with 586 
disease. Therefore, it was hypothesised to use C. albicans as a structural 587 
scaffold to gain entry into the host. Further studies have confirmed this, where 588 
C. albicans appeared to assist the invasive capacity of C. glabrata within an in 589 
vitro reconstituted epithelial biofilm model (Silva et al., 2011). The mechanistic 590 
of this interaction are at present unknown, however we can speculate that 591 
tissue destruction through proteolytic and lipolytic enzymes augments the 592 
invasive capacity of the hyphae and allows co-aggregative C. glabrata to 593 
enter and contribute to pathogenesis. Further work by this group has shown 594 
similar data with work in a reconstituted human vaginal epithelial model, 595 
where C. glabrata individually caused minimal tissue damage, though there 596 
was a significant increase in C. glabrata colonisation and invasiveness in 597 
combination with C. albicans (Alves et al., 2014). Damage was primarily 598 
dependent on the process of invasion, with key virulence genes upregulated 599 
(HWP1, PLD1 and ALS3). Further studies using in vivo models to investigate 600 
the pathogenesis of denture stomatitis would be useful in this context (Nett et 601 
al., 2010), although as described above there is mounting evidence that 602 
hitchhiking through adhesion to hyphae is not a limited phenomenon and may 603 
also be important with respect to C. glabrata using C. albicans to gain entry to 604 
the host (Schlecht et al., 2015). 605 
 606 
Anaerobic Gram-negative interactions 607 
Life in subgingival plaque is highly anaerobic, favouring many obligate PD 608 
pathogens such as P. gingivalis, F. nucleatum and P. intermedia. However, 609 
given the undefined relationship between Candida spp and PD, then this 610 
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remains a relatively neglected area of research. Studies regarding C. albicans 611 
and P. gingivalis have produced conflicting results It was shown that P. 612 
gingivalis suppressed Candida biofilm formation through a reduction in the 613 
number of viable yeast cells coincidental with an increasing P. gingivalis 614 
concentration (Thein et al., 2006). Conversely, it was also shown that P. 615 
gingivalis induces germ-tube formation in C. albicans, producing a more 616 
invasive phenotype, thus increasing the risk of infection (Nair et al., 2001).  617 
Furthermore, both microbes appear to have an antagonistic effect on one 618 
another in relation to host cell adhesion, as P. gingivalis inhibited adhesion of 619 
C. albicans to buccal epithelial cells (Nair & Samaranayake, 1996), whilst the 620 
presence of C. albicans did not enhance adhesion to gingival epithelial cells 621 
or gingival fibroblasts by P. gingivalis (Tamai et al., 2011). Yet, in the same 622 
study pre-exposure of gingival epithelial cells and fibroblasts to C. albicans 623 
enhanced cell invasion by P. gingivalis. Clearly, further studies are required to 624 
decipher how these microorganisms interact with one another.  625 
 626 
As for F. nucleatum, co-aggregation studies have revealed its ability to adhere 627 
to C. albicans species (Grimaudo & Nesbitt, 1997), as well as C. dubliniensis 628 
(Jabra-Rizk et al., 1999). However, the interaction with C. albicans may be 629 
temperature dependant as C. albicans grown at 37oC did not co-aggregate 630 
with F. nucleatum, yet the two species did co-aggregate when grown at 25oC 631 
and 45oC (Jabra-Rizk et al., 1999). The exact mechanistic behind these 632 
interactions remain unknown, however these observations indicate C. 633 
albicans- F. nucleatum interactions may be an important factor in oral 634 
colonisation by yeasts.  635 
 636 
Studies using lipopolysaccharide (LPS) from a variety of Gram-negative 637 
strains have shown that hyphal formation is inhibited as is biofilm formation in 638 
a number of Candida spp. (Bandara et al., 2010), indicating that physical 639 
interaction may be an important factor in defining their subgingival niches. 640 
Subsequent work in Escherichia coli demonstrated that secreted elements 641 
also play an important role in affecting hyphal formation (Bandara et al., 642 
2013). This is also true of the relationship between the capnophilic bacterium 643 
A. actinomycetemcomitans where it has been shown that its release of AI-2 644 
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was actively involved in inhibiting C. albicans hyphal growth and biofilm 645 
formation (Bachtiar et al., 2014). Given the complexity of various metabolites 646 
and QS molecules in subgingival plaque, such as volatile sulphur compounds, 647 
fatty acids and AI-2 (Kurita-Ochiai et al., 1995, Huang et al., 2011, Jang et al., 648 
2013, Basic & Dahlen, 2014), it is likely these also impact hyphal formation 649 
and Candida’s ability to contribute to PD (Noverr & Huffnagle, 2004). This 650 
anoxic environment has been shown to result in significant transcriptional 651 
changes in C. albicans, including the upregulation of WOR1, which is a 652 
transcriptional regulator central to phenotypic switching (Fox et al., 2014).  653 
Based on the available literature it could be surmised that subgingival plaque 654 
is most likely to antagonise yeast proliferation, except in cases where there is 655 
dysbiosis of the biofilm ecology, such as following broad-spectrum antibiotic 656 
therapy or pre-existing medical conditions, including diabetes (Rams et al., 657 
1990, Sardi et al., 2010, Al Mubarak et al., 2013).  658 
 659 
Facultative Gram-positive interactions 660 
Candida species and E. faecalis have become increasingly noted for their co-661 
isolation within endodontic infections, both of which play an important role in 662 
nosocomial infection. Interestingly, data from a longitudinal study carried out 663 
over two years at a German teaching hospital found that Candida positive 664 
patients (blood, CSF, skin, feaces or sputum) were twice as likely to be co-665 
colonised by E. faecalis (Hermann et al., 1999). E. faecalis has been found to 666 
incorporate itself into Candida biofilms, and is the third most predominant 667 
bacterial spp. found in mucosal fungal biofilms (Dongari-Bagtzoglou et al., 668 
2009, Fox et al., 2014). It was shown to adhere to Candida in both hyphal and 669 
yeast forms, yet caused a reduction in the overall biofilm biomass (Fox et al., 670 
2014). However, Cruz and colleagues (2013) demonstrated that E. faecalis 671 
inhibited hyphal morphogenesis, which was partially dependent on the Fsr 672 
quorum-sensing system, a major regulator of E. faecalis virulence (Cruz et al., 673 
2013). Collectively, these effects both impacted virulence during co-infection 674 
when compared to mono-species infection, suggesting that they both 675 
negatively influence one another’s virulence and help maintain a commensal 676 
relationship (Garsin & Lorenz, 2013). Further work has revealed that C. 677 
albicans releases a surface protein Msb2, which binds to host antimicrobial 678 
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peptides as well as antibiotics, thus conferring protection to both organisms 679 
(Swidergall et al., 2013). Furthermore, evaluating the influence of C. albicans 680 
on the dynamics of the bacterial microbiome following antibiotic treatment 681 
found that bacterial re-colonisation was enhanced in the presence of C. 682 
albicans (Mason et al., 2012). Moreover, C. albicans reduced Lactobacillus 683 
spp. whilst enhancing E. faecalis numbers, which led to the persistence of E. 684 
faecalis long term. This effect was not apparent in subjects when C. albicans 685 
was absent. Whether this effect was due to a synergistic relationship with E. 686 
faecalis or an antagonistic interaction with lactobacilli remains to be elucidated.  687 
 688 
There is a conceived dogma that lactobacilli antagonise candidal colonisation 689 
(Young et al., 1956). This forms the basis of why they play a key role in 690 
probiotics. It is well documented that probiotics reduces candidal levels at 691 
several sites, including oral cavity, bloodstream and urinary tract (Mendonca 692 
et al., 2012, Kumar et al., 2013). Early observations indicate that C. albicans 693 
decreased in the presence of lactobacilli through provision of nutrients for 694 
lactobacilli that leads to lactic acid production, thus hindering candidal growth 695 
through pH dependant inhibition. This dynamic relationship suggests that 696 
there is a close association between the two, but to date this has mainly been 697 
observed in vaginal infection. Our own microbiome studies of the denture 698 
plaque have shown that C. albicans and lactobacilli are positively associated 699 
in disease (unpublished work). The role of lactobacilli in maintaining 700 
homeostasis at the vaginal mucosa initially came to light due to the 701 
occurrence of vaginal candidiasis during treatment with systemic antibiotics. 702 
The mechanisms by which Lactobacillus species inhibits growth and virulence 703 
of Candida spp. are not yet fully understood, but perhaps the production of 704 
hydrogen peroxide as it has been shown to cause anti-candidal activity, albeit 705 
in some strains of lactobacilli (Strus et al., 2005). This suggests that other 706 
interactive mechanisms are involved in disease, including the modulation of 707 
the host response whereby lactobacilli cells have been shown to up-regulate 708 
inflammatory cytokines when co-cultured with C. albicans (Martinez et al., 709 
2009), potentially assisting in the clearance of candidal infection. Despite the 710 
overwhelming evidence of an antagonistic interaction, certain species of oral 711 
Lactobacillus, namely L. casei, have demonstrated a stimulatory effect on C. 712 
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albicans hyphal growth (Orsi et al., 2014), and in fact it has been 713 
demonstrated that candidal hyphae have the capacity to co-aggregate and 714 
support lactobacilli levels in patients with higher levels of oral disease (Bilhan 715 
et al., 2009). Nevertheless, further studies are required to investigate these 716 
interactions in detail to determine the true extent of the dynamic relationship; 717 
particularly as the conceived antagonism may only exist for C. albicans. For 718 
example, recent studies have shown that only one of six probiotic 719 
Lactobacillus species had an inhibitory effect on C. glabrata growth (Jiang et 720 
al., 2015). This suggests that the interaction between Candida and lactobacilli 721 
may be dependant on the particular environment they co-habit. 722 
 723 
Conclusions  724 
Collectively, these data demonstrate that the interaction between candidal 725 
species and other microoorganisms may be dependant on the nature of the 726 
interaction (chemical, physical, or both) and the particular environment they 727 
cohabit. It is clear from many of these studies that the interaction between C. 728 
albicans hyphae and different bacterial species is important in defining their 729 
interaction, whether mutualistic or antagonistic in nature. The secretion of 730 
signalling molecules from the myriad of microorganisms in the oral cavity, 731 
such as AI-2, farnesol, and other small molecules is clearly important, with 732 
recent studies supporting the notion that the metabolome plays an integral 733 
part in defining the interaction between the host, Candida and microbiota such 734 
as lactobacilli (Romani et al., 2015). Understanding how each of these 735 
specific interactions influences one another and Candida’s pathogenicity will 736 
enable us to target this medically important yeast rationally. Though, we must 737 
be cognisant of the negative influences of changing its role within complex 738 
oral biofilm communities and the consequences of dysbiosis (McLean, 2014), 739 
as this may support the unnecessary proliferation and overgrowth of candidal 740 
yeasts that leads to oral disease. 741 
 742 
 743 
 744 
 745 
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 1329 
Figure legends 1330 
 1331 
Figure 1: Interactions between Candida albicans and bacteria. 1332 
Candida albicans coaggregating with either (A) Gram-negative and (B) Gram-1333 
positive bacteria, or (C) a polymicrobial biofilm aggregate consisting of Gram-1334 
positive and Gram-negative oral bacterial species interacting with C. albicans 1335 
hyphae. White scale bars = 20um. Confocal Image taken by Dr Owain 1336 
Millington, Biophotonics Unit, Strathclyde University) 1337 
 1338 
Figure 2: Oral sites of polymicrobial Candida biofilm diseases. 1339 
The schematic diagram illustrates site within the oral cavity typically where 1340 
Candida-bacterial polymicrobial biofilms are observed (clockwise from top 1341 
position): caries, periodontitis, orthodontic, endodontic, angular cheilitis, 1342 
denture stomatitis. 1343 
 1344 
Figure 3: Micrographs of polymicrobial Candida denture related 1345 
biofilms. (A) Scanning electron micrograph (SEM) and (B) confocal laser 1346 
scanning micrograph (CLSM) of complex bacterial communities 1347 
coaggregating with Candida albicans upon denture acrylic. These 1348 
micrographs show low (SEM) and high (CLSM) magnifications of mixtures of 1349 
C. albicans yeast (round) and hyphae (long filaments – white arrows) 1350 
coaggregated with smaller bacterial species. Confocal Image taken by Dr 1351 
Owain Millington, Biophotonics Unit, Strathclyde University). 1352 
 1353 
Figure 4: Development of polymicrobial Candida biofilm on denture 1354 
acrylic. This schematic representation of denture biofilm development shows 1355 
how initial colonisation by yeast and bacterial species (white), followed by 1356 
hyphal formation and co-aggregation (grey), which then enables the bacterial 1357 
species to expand and grow into the spaces unoccupied on the surface of 1358 
both the acrylic and C. albicans hyphae (black).  1359 
 39 
 1360 
Figure 5: Candida albicans and Staphylococcus aureus polymicrobial 1361 
biofilm. This confocal scanning laser micrograph shows the close interactions 1362 
between clusters of S. aureus (yellow) and C. albicans hyphae (white/green). 1363 
The appearance of these interactions demonstrates close attachment 1364 
between the two in three-dimensional space, suggesting structural stability 1365 
and an element of co-operation with one-another. Confocal Image taken by Dr 1366 
Owain Millington, Biophotonics Unit, Strathclyde University) 1367 
